|
1
|
Kuang SQ, Bai H, Fang ZH, et al: Aberrant
DNA methylation and epigenetic inactivation of Eph receptor
tyrosine kinases and ephrin ligands in acute lymphoblastic
leukemia. Blood. 115:2412–2419. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Whitman SP, Hackanson B, Liyanarachchi S,
et al: DNA hypermethylation and epigenetic silencing of the tumor
suppressor gene, SLC5A8, in acute myeloid leukemia with the MLL
partial tandem duplication. Blood. 112:2013–2016. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hammond NL and Jahoda CA: Id2, Id3, and
Id4 proteins show dynamic changes in expression during vibrissae
follicle development. Dev Dyn. 237:1653–1661. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu L, Liu C, Vandeusen J, et al: Global
assessment of promoter methylation in a mouse model of cancer
identifies ID4 as a putative tumor-suppressor gene in human
leukemia. Nat Genet. 37:265–274. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Laing JG, Koval M and Steinberg TH:
Association with ZO-1 correlates with plasma membrane partitioning
in truncated connexin45 mutants. J Membr Biol. 207:45–53. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Hoover KB, Liao SY and Bryant PJ: Loss of
the tight junction MAGUK ZO-1 in breast cancer: relationship to
glandular differentiation and loss of heterozygosity. Am J Pathol.
153:1767–1773. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang C, Tan Y, Wang G, et al: Study on the
relationship between ZO-1 gene expression and the methylation
regulation in acute leukemia. Shandong Med J. 32:0022007.(In
Chinese).
|
|
8
|
Zhao Y, Wang QS, Li HH, et al:
Significance of ID4 promoter methylation in monitoring AML patients
with complete remission. Zhongguo Shi Yan Xue Ye Xue Za Zhi.
16:476–478. 2008.(In Chinese).
|
|
9
|
Butler TM and Fletcher GL: Promoter
analysis of a growth hormone transgene in Atlantic salmon.
Theriogenology. 72:62–71. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Papageorgio C, Harrison R, Rahmatpanah FB,
Taylor K, Davis W and Caldwell CW: Algorithmic discovery of
methylation ‘hot spots’ in DNA from lymphoma patients. Cancer
Inform. 6:449–453. 2008.PubMed/NCBI
|
|
11
|
Noetzel E, Veeck J, Niederacher D, et al:
Promoter methylation-associated loss of ID4 expression is a marker
of tumour recurrence in human breast cancer. BMC Cancer. 8:1542008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Esteller M: Epigenetics in cancer. N Engl
J Med. 358:1148–1159. 2008. View Article : Google Scholar
|
|
14
|
Krug U, Ganser A and Koeffler HP: Tumor
suppressor genes in normal and malignant hematopoiesis. Oncogene.
21:3475–3495. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miyamoto K and Ushijima T: Diagnostic and
therapeutic applications of epigenetics. Jpn J Clin Oncol.
35:293–301. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Paz-Carreira J, Garcia-Rivero A, Losada R,
et al: Prognostic significance of promoter methylation of multiple
genes in germinal center hyperplasia (GCH) and lymphomas of
germinal center origin. Blood. 135:114–122. 2009.
|
|
17
|
Delgado J: Novel epigenetic targets in
lymphoproliferative disorders. Curr Cancer Drug Targets. 8:378–391.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Murray PG, Fan Y, Davies G, et al:
Epigenetic silencing of a proapoptotic cell adhesion molecule, the
immunoglobulin superfamily member IGSF4, by promoter CpG
methylation protects Hodgkin lymphoma cells from apoptosis. Am J
Pathol. 177:1480–1490. 2010. View Article : Google Scholar
|
|
19
|
Amara K, Trimeche M, Ziadi S, Laatiri A,
Hachana M and Korbi S: Prognostic significance of aberrant promoter
hypermethylation of CpG islands in patients with diffuse large
B-cell lymphomas. Ann Oncol. 19:1774–1786. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eberth S, Schneider B, Rosenwald A, et al:
Epigenetic regulation of CD44 in Hodgkin and non-Hodgkin lymphoma.
BMC Cancer. 10:5172010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Conway K, Edmiston SN, Khondker ZS, et al:
DNA-methylation profiling distinguishes malignant melanomas from
benign nevi. Pigment Cell Melanoma Res. 24:352–360. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Carey JP, Asirvatham AJ, Galm O, Ghogomu
TA and Chaudhary J: Inhibitor of differentiation 4 (Id4) is a
potential tumor suppressor in prostate cancer. BMC Cancer.
9:1732009. View Article : Google Scholar : PubMed/NCBI
|
